International Stem Cell Corporation
ISCO
$0.115
$0.02527.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -205.04% | 155.61% | 53.28% | -249.62% | -126.63% |
| Total Depreciation and Amortization | 6.00% | 2.04% | 2.08% | 2.13% | -2.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.88% | 21.20% | 3.83% | 1.95% | -3.30% |
| Change in Net Operating Assets | 139.85% | -66.94% | -167.68% | 713.56% | 77.48% |
| Cash from Operations | 1,017.39% | 111.92% | -219.88% | 159.68% | -87.35% |
| Capital Expenditure | 69.17% | -1,400.00% | -- | 100.00% | 72.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -400.00% | 200.00% | 66.67% | -- | -- |
| Cash from Investing | 66.39% | -1,222.22% | -200.00% | 78.57% | 72.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.71% | 52.48% | -227.85% | 229.17% | -89.07% |
